NASDAQ:SGHT Sight Sciences Q3 2026 Earnings Date & Estimates $8.89 +0.42 (+4.96%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$8.88 -0.01 (-0.11%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sight Sciences is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sight Sciences in Q3 2026Sight Sciences is expected to post earnings of -$0.13 per share on revenue of $23.55 million. In the same quarter a year earlier Sight Sciences reported -$0.16 per share on revenue of $19.91 million. Sight Sciences last reported on August 5, 2026, posting -$0.08 per share and beating the -$0.1833 consensus estimate. Sight Sciences has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.13Expected Revenue$23.55 millionPrior-Year EPS-$0.16Prior-Year Revenue$19.91 millionExpected Revenue Growth+18.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.08 (Beat by +$0.1033)Last Quarter Revenue$23.39 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Sight Sciences Q3 2026 Earnings FAQ When does Sight Sciences report Q3 2026 earnings? Sight Sciences (NASDAQ:SGHT) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. What time is Sight Sciences' Q3 2026 earnings call? Sight Sciences' Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Sight Sciences? Analysts expect Sight Sciences to post earnings of -$0.13 per share for Q3 2026. How much revenue is Sight Sciences expected to report? The consensus revenue estimate for Sight Sciences is $23.55 million for Q3 2026. Sight Sciences Earnings HeadlinesSight Sciences: Signs Of Progress, But Plenty Of Work RemainsOctober 9 at 1:00 PM | seekingalpha.comSight Sciences (SGHT) Stock Gets Fair Value Boost After Analyst Target IncreasesOctober 8 at 8:05 PM | uk.finance.yahoo.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.October 10 at 1:00 AM | Banyan Hill Publishing (Ad)Sight Sciences (NASDAQ:SGHT) Stock: Insider James Rodberg Sells 7,208 SharesOctober 7 at 5:22 AM | americanbankingnews.comAnalyzing Innovative Eyewear (NASDAQ:LUCY) & Sight Sciences (NASDAQ:SGHT)October 4, 2026 | americanbankingnews.comSight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of ...October 1, 2026 | markets.businessinsider.comSee More Sight Sciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sight Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sight Sciences and other key companies, straight to your email. Email Address About Sight SciencesSight Sciences (NASDAQ:SGHT) is a medical technology company focused on developing and commercializing treatments for ophthalmic diseases. The company designs devices intended to address underlying causes of conditions such as glaucoma and dry eye disease, with an emphasis on less invasive procedures that can be performed in clinical settings. Its product portfolio includes the OMNI Surgical System, a device used in minimally invasive glaucoma surgery to perform canaloplasty and trabeculotomy procedures. Sight Sciences also offers the TearCare System, which is designed to apply controlled thermal therapy to the eyelids to help treat meibomian gland dysfunction, a common contributor to evaporative dry eye disease. Founded in 2010 and headquartered in Menlo Park, California, Sight Sciences markets its products primarily through ophthalmology and optometry practices. The company serves eye-care providers and patients in the United States and has pursued international commercialization of its technologies. Sight Sciences trades on the Nasdaq under the symbol SGHT.View Sight Sciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
